India’s Pharma Exports Cross $30 Billion in FY25, with US as Top Buyer

India’s pharmaceutical industry exported medicines worth over $30 billion in the financial year 2024–25, according to official trade data. The United States remained the biggest buyer of Indian drugs, showing strong demand for affordable and high-quality medicines.

Indian companies exported a wide range of pharmaceutical products, including generic medicines, vaccines, and active pharmaceutical ingredients (APIs). The strong export numbers highlight India’s growing role as a global supplier of healthcare products.

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) released the data this week. It showed that Indian drugmakers increased exports by over 8% compared to the previous year. The US alone accounted for nearly 30% of total exports, followed by markets like the United Kingdom, South Africa, Brazil, and Russia.

“Indian pharma companies delivered strong export growth this year despite global economic challenges,” said a senior official from Pharmexcil. “Our companies focused on quality, affordability, and timely delivery, which helped maintain demand in key markets.”

The government supported the industry by improving approval processes, promoting manufacturing under the Production Linked Incentive (PLI) scheme, and strengthening regulatory systems. These efforts helped Indian companies compete more effectively in global markets.

India also expanded its exports to emerging countries in Africa, Latin America, and Southeast Asia. Indian drugmakers met the growing need for affordable medicines in developing countries, especially during health emergencies and outbreaks.

Industry experts said that India’s strong production base, skilled workforce, and focus on generic medicines played a key role in crossing the $30 billion mark. They also praised the industry’s quick response to global health needs, including the supply of vaccines and life-saving drugs.

Looking ahead, Indian pharma companies plan to invest more in research, innovation, and partnerships to keep up their global presence. They aim to grow exports further by reaching new markets and increasing the supply of high-value medicines.

With strong demand and government support, India’s pharmaceutical exports are expected to remain a major part of the country’s trade growth in the coming years.